Kimberlee C. Drapkin, CFO and Treasurer at Jounce Therapeutics, Inc. (JNCE), sold 5,267 shares at $21.21 ($113K) on 2018-03-05, disclosed to the SEC on 2018-03-07.
Open-market sale of $113k JNCE by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.21 | 4,000 | $85K | 75.2% |
| 2 | $22.07 | 1,267 | $28K | 24.8% |
| Total | $21.42 avg | 5,267 | $113K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-22 | $536K | — | Filing → |
| JNCE | SELL | 2021-01-11 | $40K | — | Filing → |
| JNCE | SELL | 2020-09-02 | $58K | — | Filing → |